AROMALYN – Driada (EU) | Premium Exemestane for Advanced Estrogen Control

AROMALYN – Elite Estrogen Suppression by Driada (EU)

AROMALYN from Driada Medical (EU) is a top-tier aromatase inhibitor (AI) containing Exemestane, renowned for its “suicidal” mechanism—permanently deactivating the aromatase enzyme. This irreversible binding ensures robust estrogen control when running aromatizable compounds, making AROMALYN the go-to choice for:

Bulking cycles with testosterone, Deca, or Dianabol
Cutting phase to preserve hard, lean muscle
Testosterone replacement therapy (TRT) to maintain hormone balance
Post-cycle therapy (PCT) to flush residual estrogen

What Makes Exemestane Superior?

Irreversible aromatase inhibition: Exemestane permanently “suicides” the enzyme, preventing any rebound conversion.
Minimal impact on cholesterol: Less detrimental to HDL levels compared to some other AIs.
Rapid onset: Noticeable estrogen reduction within days of the first dose.
Favorable side-effect profile: Less joint pain and mood disturbance versus harsher AIs.

Key Benefits of AROMALYN

✅ Prevent and reverse gynecomastia by halting estrogen production at the source
✅ Reduce water retention and puffiness for a drier, more vascular look
✅ Support lean muscle preservation during calorie deficits or intense training
✅ Enhance libido and mood stability by maintaining an optimal testosterone-to-estrogen ratio
✅ Ideal for both on-cycle support and PCT—flexible dosing protocols

Suggested Dosage & Protocols

Use Case	Dose (per day)	Frequency	Duration
On-cycle Estrogen Control	12.5–25mg	Every other day	Entire cycle
High-dose Testosterone	25mg	Every other day	Adjust per bloodwork
PCT Support	12.5–25mg	Daily until stable	2–3 weeks post-cycle
TRT Maintenance	12.5mg	2–3x per week	Ongoing

Tip: Start at the lower end (12.5mg EOD) and adjust based on symptoms and bloodwork. Avoid over-suppressing estrogen, which can cause joint discomfort and low libido.